F. UHLMANN-EYRAUD AG
- Sector unverified
- Rank 214 / 334
F. UHLMANN-EYRAUD AG is recorded by Swissmedic as the authorisation holder for 4 human medicines, which places it 214 of 334 authorisation holders. Its portfolio is mostly in the Synthetika category (100 % of its authorisations). We hold no research of our own on this company's sector or business model, so we assign it to none.
Sector unverified: the Swissmedic list carries no sector field and we have not researched this company.
Key facts
| Sector | Not available |
|---|---|
| City | Not available |
| Canton | Not available |
| Authorisation holder | Yes |
| Medicines | 4 |
| Founded | Not available |
| Employees | Not available |
| Parent group | Not available |
| Activity | Not available |
| Website | Not available |
Medicines authorised in Switzerland
F. UHLMANN-EYRAUD AG is recorded by Swissmedic as the authorisation holder for 4 human medicines. The table shows 4 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
4 of 4 authorisations
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| Aspégic 100 | 38133 | B/D | N02BA01 | 1977-07-06 |
| Debridat 100 | 45427 | B | A03AA05 | 1990-03-29 |
| Neutroses | 8978 | D | - | 1937-02-28 |
| Warz-ab/Extor | 17035 | D | D11AF | 1952-06-14 |
Frequently asked questions
How many medicines does F. UHLMANN-EYRAUD AG have authorised in Switzerland?
F. UHLMANN-EYRAUD AG is recorded by Swissmedic as the authorisation holder for 4 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is F. UHLMANN-EYRAUD AG based?
We have no confirmed Swiss address for F. UHLMANN-EYRAUD AG. We add it as soon as the commercial register or the company confirms it.
Is F. UHLMANN-EYRAUD AG a Swissmedic authorisation holder?
Yes. F. UHLMANN-EYRAUD AG appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.